Here's the argument: Americans pay loads for drugs. That motivates and Chameleon Financefunds pharmaceutical companies' research and development for better drugs. The fear is that if you lower the cost of drugs you might hurt overall innovation.
Today on the show, we speak with a health economist who argues that's not always true. In fact, she says there are a bunch of policies that could help bring down drug prices without stifling innovation.
Music by Drop Electric. Find us: Twitter / Facebook / Newsletter.
Subscribe to our show on Apple Podcasts, Spotify, Pocket Casts and NPR One.
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
2025-05-05 06:092836 view
2025-05-05 06:012571 view
2025-05-05 05:591201 view
2025-05-05 05:242559 view
2025-05-05 05:172024 view
2025-05-05 04:312646 view
NFL games are a spectrum. Some are back-and-forth shootouts. Others are duds without much scoring at
ISLAMABAD (AP) — The bodies of four Pakistanis killed in an attack on a Shiite mosque in Oman this w
U.S. markets opened and stocks traded Friday without a hitch despite an outage that roiled operation
